NCT07449845

Brief Summary

This observational study aims to assess quality of life in individuals with epilepsy using the Quality of Life in Epilepsy Inventory (QOLIE-31). A total of 90 adult patients with a clinical diagnosis of epilepsy will be evaluated through standardized questionnaires administered during routine clinical visits. The study seeks to characterize patient-reported quality of life across multiple domains and to provide insight into factors affecting daily functioning and well-being in people living with epilepsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2026

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

February 26, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 30, 2026

Status Verified

February 1, 2026

Enrollment Period

28 days

First QC Date

February 26, 2026

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of life measured by QOLIE-31 total score

    The Quality of Life in Epilepsy Inventory-31 is a validated epilepsy-specific quality of life scale consisting of 31 items. The total score ranges from 0 to 100. Higher scores indicate better health-related quality of life.

    At study enrollment

Study Arms (1)

epilepsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with a confirmed diagnosis of epilepsy who are receiving routine care at a neurology clinic and are able to complete the QOLIE-31 questionnaire will be included. The population reflects individuals with varying clinical characteristics encountered in everyday epilepsy practice.

You may qualify if:

  • Age ≥18 years
  • Clinical diagnosis of epilepsy confirmed by a neurologist
  • Ability to complete QOLIE-31 questionnaire
  • Informed consent provided

You may not qualify if:

  • Severe cognitive impairment
  • Acute medical or psychiatric condition interfering with participation
  • Inability to understand questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saglik Bilimleri University Izmir Faculty of Medicine Department of Neurology

Izmir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2026

First Posted

March 4, 2026

Study Start

February 1, 2026

Primary Completion

March 1, 2026

Study Completion

April 1, 2026

Last Updated

April 30, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations